Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Minimally Invasive Robotic Surgery for GERD

By HospiMedica staff writers
Posted on 21 May 2001
A multicenter trial is underway to evaluate the safety and effectiveness of minimally invasive robotic surgery for treating gastroesophageal reflux disease (GERD). More...
The procedure, called Nissen fundoplication, involves wrapping part of the stomach around the esophagus to create a new valve that will prevent acid from refluxing into the stomach. Half of the patients in the trial will undergo conventional minimally invasive surgery without robotic assistance. One of the participating centers is the University of Pittsburgh (PA, USA), which has issued this report.

Doctors using robotic surgery in the study are using the Zeus robotic surgical system of Computer Motion (Goleta, CA, USA), which is sponsoring the study. The benefits claimed for surgery by this system are smaller incisions, reduced trauma, shorter hospital stays and convalescent periods, improved surgeon precision and dexterity, improved visualization, and minimized surgeon fatigue.

Surgeons create five small incisions, or ports, in the upper abdomen. One is used to insert an endoscope that enables the surgeon to view the operating area. Other surgical instruments are held and moved by the Zeus system through the remaining ports. While seated at the console, the surgeon views the operative site on a high-resolution monitor and operates handles that resemble conventional surgical instruments. The surgeon's hand movements are translated by the robotic arms into precise movements, while hand tremor is filtered by the computer. The surgeon controls the endoscope through voice commands.

"These early applications and trials will allow surgeons to work together with industy to continue to apply new robotic technology to enhance patient care,” noted James D. Luketich, M.D., head of thoracic surgery at the University of Pittsburgh's Lung Cancer
Center and principal investigator in the study.




Related Links:
Univ. of Pittsburgh

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.